225 related articles for article (PubMed ID: 1327813)
1. delta-Opioid receptor binding in mouse brain: evidence for heterogeneous binding sites.
Sofuoglu M; Portoghese PS; Takemori AE
Eur J Pharmacol; 1992 Jun; 216(2):273-7. PubMed ID: 1327813
[TBL] [Abstract][Full Text] [Related]
2. Determination of delta-opioid in NG108-15 cells.
Ho BY; Holmes BB; Zhao J; Fujimoto J
Eur J Pharmacol; 1997 Jan; 319(1):109-14. PubMed ID: 9030905
[TBL] [Abstract][Full Text] [Related]
3. Ligand binding profiles of delta-opioid receptor in human cerebral cortex membranes: evidence of delta-opioid receptor heterogeneity.
Kim KW; Kim SJ; Shin BS; Choi HY
Life Sci; 2001 Feb; 68(14):1649-56. PubMed ID: 11263677
[TBL] [Abstract][Full Text] [Related]
4. Differential antagonism by naltrindole-5'-isothiocyanate on [3H]DSLET and [3H]DPDPE binding to striatal slices of mice.
Chakrabarti S; Sultana M; Portoghese PS; Takemori AE
Life Sci; 1993; 53(23):1761-5. PubMed ID: 8246672
[TBL] [Abstract][Full Text] [Related]
5. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes.
Sofuoglu M; Portoghese PS; Takemori AE
J Pharmacol Exp Ther; 1991 May; 257(2):676-80. PubMed ID: 1851833
[TBL] [Abstract][Full Text] [Related]
6. Effects of the delta-opioid receptor antagonist naltrindole on antinociceptive responses to selective delta-agonists in post-weanling rats.
Crook TJ; Kitchen I; Hill RG
Br J Pharmacol; 1992 Oct; 107(2):573-6. PubMed ID: 1330187
[TBL] [Abstract][Full Text] [Related]
7. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
Jiang Q; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI; Porreca F
J Pharmacol Exp Ther; 1991 Jun; 257(3):1069-75. PubMed ID: 1646319
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of delta receptor mediation of supraspinal opioid analgesia by in vivo protection against the beta-funaltrexamine antagonist effect.
Sánchez-Blázquez P; Garzón J
Eur J Pharmacol; 1989 Jan; 159(1):9-23. PubMed ID: 2565240
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent antagonism of spinal opioid receptor agonists by naloxone and naltrindole: additional evidence for delta-opioid receptor subtypes in the rat.
Tiseo PJ; Yaksh TL
Eur J Pharmacol; 1993 May; 236(1):89-96. PubMed ID: 8391455
[TBL] [Abstract][Full Text] [Related]
10. Opiate binding in calf thalamic membranes: a selective mu 1 binding assay.
Clark JA; Houghten R; Pasternak GW
Mol Pharmacol; 1988 Sep; 34(3):308-17. PubMed ID: 2901663
[TBL] [Abstract][Full Text] [Related]
11. Characterization of D-Ala2,Leu5,Cys6-enkephalin: a novel synthetic opioid peptide with slowed dissociation from delta receptors.
Bowen WD; Kelemen M; Huey R; Stewart D
NIDA Res Monogr; 1986; 75():193-6. PubMed ID: 2828971
[TBL] [Abstract][Full Text] [Related]
12. Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity.
Fang L; Knapp RJ; Horvath R; Matsunaga TO; Haaseth RC; Hruby VJ; Porreca F; Yamamura HI
J Pharmacol Exp Ther; 1994 Feb; 268(2):836-46. PubMed ID: 8113996
[TBL] [Abstract][Full Text] [Related]
13. The effect of naltrindole on spinal and supraspinal delta opioid receptors and analgesia.
Shah S; Davis T; Yoburn BC
Life Sci; 1994; 55(19):1451-8. PubMed ID: 7968211
[TBL] [Abstract][Full Text] [Related]
14. Postnatal development of delta-opioid receptor subtypes in mice.
Negri L; Severini C; Lattanzi R; Potenza RL; Melchiorri P
Br J Pharmacol; 1997 Mar; 120(6):989-94. PubMed ID: 9134207
[TBL] [Abstract][Full Text] [Related]
15. Chronic effect of [D-Pen2,D-Pen5]enkephalin on rat brain opioid receptors.
Tao PL; Tsai CL; Chang LR; Loh HH
Eur J Pharmacol; 1991 Aug; 201(2-3):209-14. PubMed ID: 1665782
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the interactions of mu and delta selective ligands with [3H]D-Ala2-D-Leu5-enkephalin binding to mouse brain membranes.
Barrett RW; Vaught JL
Life Sci; 1983 Dec; 33(24):2439-48. PubMed ID: 6316063
[TBL] [Abstract][Full Text] [Related]
17. Effects of NMDA receptor antagonists on delta1- and delta2-opioid receptor agonists-induced changes in the mouse brain [3H]DPDPE binding.
Cao YJ; Bian JT; Bhargava HN
Eur J Pharmacol; 1997 Sep; 335(2-3):161-6. PubMed ID: 9369369
[TBL] [Abstract][Full Text] [Related]
18. Comparative binding properties of linear and cyclic delta-selective enkephalin analogues: [3H]-[D-Thr2, Leu5] enkephalyl-Thr6 and [3H]-[D-Pen2, D-Pen5] enkephalin.
Delay-Goyet P; Zajac JM; Rigaudy P; Foucaud B; Roques BP
FEBS Lett; 1985 Apr; 183(2):439-43. PubMed ID: 2985440
[TBL] [Abstract][Full Text] [Related]
19. Differential binding of opioid peptides and other drugs to two subtypes of opioid delta ncx binding sites in mouse brain: further evidence for delta receptor heterogeneity.
Xu H; Partilla JS; de Costa BR; Rice KC; Rothman RB
Peptides; 1993; 14(5):893-907. PubMed ID: 8284266
[TBL] [Abstract][Full Text] [Related]
20. Delta opioid antagonist activity and binding studies of regioisomeric isothiocyanate derivatives of naltrindole: evidence for delta receptor subtypes.
Portoghese PS; Sultana M; Nelson WL; Klein P; Takemori AE
J Med Chem; 1992 Oct; 35(22):4086-91. PubMed ID: 1331455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
